Practical synthetic approaches to several new """"""""purine-like"""""""" C-nucleosides are described. These substances are structurally related to several new purine nucleoside antimetabolites synthesized recently in our laboratory, namely the 9-deazapurine C-nucleosides and their thieno analogs which have exhibited exceptional growth inhibitory activities. Rationales are offered which are based on: a) the demonstrated anticancer activities of the lead C-nucleosides, and b) other biochemical considerations. It is suggested that several of the candidates may possess higher chemotherapeutic indices than the original lead compounds and that some may exhibit useful antiviral properties. """"""""In-house"""""""" biochemical and biological studies for the proper antitumor evaluation of all target C-nucleosides are described. Relationships between chemical structures and anticancer activity should be ascertainable from these investigations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA024634-07
Application #
3166517
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1979-02-01
Project End
1986-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
7
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Bartlett, M S; Marr, J J; Queener, S F et al. (1986) Activity of inosine analogs against Pneumocystis carinii in culture. Antimicrob Agents Chemother 30:181-3
Stoeckler, J D; Ryden, J B; Parks Jr, R E et al. (1986) Inhibitors of purine nucleoside phosphorylase: effects of 9-deazapurine ribonucleosides and synthesis of 5'-deoxy-5'-iodo-9-deazainosine. Cancer Res 46:1774-8